# Characterization of Neuromuscular Function and Fatigue After Breast Cancer Treated With Adjuvant Chemotherapy (PROTECT-04)

> **NCT04639609** · NA · COMPLETED · sponsor: **Institut de cancérologie Strasbourg Europe** · enrollment: 30 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **OTHER:** Characterization of Neuromuscular Function and Fatigue

## Key facts

- **NCT ID:** NCT04639609
- **Lead sponsor:** Institut de cancérologie Strasbourg Europe
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-29
- **Primary completion:** 2021-09-06
- **Final completion:** 2021-09-06
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2021-09-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04639609

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04639609, "Characterization of Neuromuscular Function and Fatigue After Breast Cancer Treated With Adjuvant Chemotherapy (PROTECT-04)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04639609. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*